Abbott’s blood tests can predict patient recovery from brain injury
Abbott's i-STAT TBI Plasma test and ARCHITECT core laboratory instrument were used to measure the two biomarkers.

Abbott's i-STAT TBI Plasma test and ARCHITECT core laboratory instrument were used to measure the two biomarkers.
Paige will provide Sonora Quest Laboratories with Paige Breast, Paige Prostate Detect and its FullFocus viewer.
The test can be integrated into electronic health records to help clinicians counsel patients.
Empyrean and MD Anderson will combine their expertise to improve radiation therapy delivery for cancer patients.
To better identify early-onset cancer, the researchers eliminated the miRNA markers shared by early-onset and late-onset patients.
The new device can be integrated with a smartwatch and continuously monitors biosignals.
The companies will combine their capabilities to advance flow cytometry as an essential CDx modality for cancer.
The Bodyport Cardiac Scale allows individuals with fluid management conditions to monitor heart function and fluid status.
Thank you for subscribing to Medical Device Network